Together with currently discussed cell-activation markers (sTREM-1, ESM-1, cfDNA, monocyte responsiveness) we wanted to establish differences in the immune status of the cardiac surgery patients that have an uneventful recovery and those that develop SIRS/sepsis for timely intervention. The gene discussed is ESM1; the disease is Sepsis.